BridgeBio Pharma, Inc 10-Q for FY2021 Q1
BridgeBio Pharma, Inc. (BBIO)
10-Q
2021-05-06
For: 2021-03-31
View Original
Added on
April 08, 2026
About this 10-Q
BridgeBio Pharma, Inc filed this 10-Q on May 6, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).
Headline figures
Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $462K
- Net loss
- $171.08M
- compared with a net loss of $104.08M a year earlier